Clinical Relevance of Liquid Chromatography Tandem Mass Spectrometry as an Analytical Method in Microdose Clinical Studies

[1]  S. Ono.  Ministry of Health, Labour and Welfare (MHLW, Japan) , 2007 .

[2]  J. Posner,et al.  The disposition of bupropion and its metabolites in healthy male volunteers after single and multiple doses , 2004, European Journal of Clinical Pharmacology.

[3]  R. C. Garner,et al.  A Review of Human Phase 0 (Microdosing) Clinical Trials Following the US Food and Drug Administration Exploratory Investigational New Drug Studies Guidance , 2006, International Journal of Pharmaceutical Medicine.

[4]  D. Musson,et al.  Application of a novel ultra-low elution volume 96-well solid-phase extraction method to the LC/MS/MS determination of simvastatin and simvastatin acid in human plasma. , 2005, Journal of pharmaceutical and biomedical analysis.

[5]  James L. Gilbert,et al.  Rebuilding Big Pharma ’ s Business Model , 2022 .

[6]  M. Kanai,et al.  A concise synthesis of Tamiflu: third generation route via the Diels–Alder reaction and the Curtius rearrangement , 2007 .

[7]  Yu-mei Chi,et al.  Determination of donepezil hydrochloride (E2020) in plasma by liquid chromatography-mass spectrometry and its application to pharmacokinetic studies in healthy, young, Chinese subjects. , 2004, Journal of chromatographic science.

[8]  R. Colin Garner,et al.  Big physics, small doses: the use of AMS and PET in human microdosing of development drugs , 2003, Nature Reviews Drug Discovery.

[9]  R. Hargreaves,et al.  Clinical biomarkers in drug discovery and development , 2003, Nature Reviews Drug Discovery.

[10]  Yuichi Sugiyama,et al.  Microdose clinical trial: quantitative determination of nicardipine and prediction of metabolites in human plasma. , 2009, Drug metabolism and pharmacokinetics.

[11]  L. Babiss,et al.  Toxicogenomics in predictive toxicology in drug development. , 2004, Chemistry & biology.

[12]  Malcolm Rowland,et al.  Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs , 2006, Clinical pharmacology and therapeutics.

[13]  W G Laver,et al.  Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. , 1997, Journal of the American Chemical Society.

[14]  M. Nakashima,et al.  Phase I Study of MK-954, a New Angiotensin II Receptor Antagonist , 1995 .

[15]  Jean W. Lee,et al.  A general approach for the quantitative analysis of bisphosphonates in human serum and urine by high-performance liquid chromatography/tandem mass spectrometry. , 2006, Rapid communications in mass spectrometry : RCM.

[16]  Yuichi Sugiyama,et al.  Microdose clinical trial: quantitative determination of fexofenadine in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.